Recurrent YAP1::MAML2 fusions in “nodular necrotizing” variants of myxoinflammatory fibroblastic sarcoma: a comprehensive study of 7 cases
- 11 May 2022
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 35 (10) , 1398-1404
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- HTSeq—a Python framework to work with high-throughput sequencing dataBioinformatics, 2014
- voom: precision weights unlock linear model analysis tools for RNA-seq read countsGenome Biology, 2014
- Myxoinflammatory Fibroblastic SarcomaAmerican Journal of Surgical Pathology, 2014
- Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumorGenes, Chromosomes and Cancer, 2011
- YAP1 and VGLL3, encoding two cofactors of TEAD transcription factors, are amplified and overexpressed in a subset of soft tissue sarcomasGenes, Chromosomes and Cancer, 2010
- Management of acral myxoinflammatory fibroblastic sarcomaCancer, 2010
- ConsensusClusterPlus: a class discovery tool with confidence assessments and item trackingBioinformatics, 2010
- Two genetic pathways, t(1;10) and amplification of 3p11–12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesionsThe Journal of Pathology, 2009
- Acral Myxoinflammatory Fibroblastic SarcomaAmerican Journal of Surgical Pathology, 1998
- Inflammatory Myxoid Tumor of the Soft Parts with Bizarre Giant CellsPathology - Research and Practice, 1998